-
French patent attorney’s figures show Paris patent court filings falling sharply since UPC launch
Read more: French patent attorney’s figures show Paris patent court filings falling sharply since UPC launchA French patent litigator has published data suggesting a correlation between the UPC’s arrival and falling patent case numbers before France’s sole first-instance patent court, fueling fresh discussion about the UPC’s impact on national litigation systems.
-
Apple hit with Central District of California complaint over video call patents linked to Intellectual Discovery
Read more: Apple hit with Central District of California complaint over video call patents linked to Intellectual DiscoveryApple has been targeted with other patents connected to the South Korean NPE in recent months.
-
Hisense targeted by Fortress-backed NPE asserting former TCL China Star patents in Eastern District of Texas
Read more: Hisense targeted by Fortress-backed NPE asserting former TCL China Star patents in Eastern District of TexasDebate has grown around the “anti-NPE” LOT Network recently; TCL’s withdrawal last year suggests the company is seeking more flexibility with regards to its patent strategy.
-
Think twice before filing in the UPC if you foresee a private-prior-use defense under German law: further Fujifilm v. Kodak analysis
Read more: Think twice before filing in the UPC if you foresee a private-prior-use defense under German law: further Fujifilm v. Kodak analysisThere are opportunities in the UPC, but sometimes there can be a downside. The CoA’s Fujifilm v. Kodak decision lays out a permissive approach to (German) prior use in evidentiary, substantive, and procedural terms.
-
Incyte acquires bleeding-disorder biotech Vega Therapeutics as Jakafi patent cliff looms
Read more: Incyte acquires bleeding-disorder biotech Vega Therapeutics as Jakafi patent cliff loomsIncyte will pay $1.25 billion upfront for Vega Therapeutics, with up to $750 million more in sales milestones. The $2.4 billion-a-year drug loses U.S. exclusivity in December 2028 after a pediatric extension.
-
UPC Roundup (1 week): security decisions (no SME bonus, parent company doesn’t count); two failed infringement lawsuits; more
Read more: UPC Roundup (1 week): security decisions (no SME bonus, parent company doesn’t count); two failed infringement lawsuits; moreThis is a summary of developments in and around the UPC in the calendar week of June 1, 2026.
-
BREAKING: Avanci signed up four Chinese automakers as licensees between early April and now; 11 Chinese licensees in total, 17 contracts
Read more: BREAKING: Avanci signed up four Chinese automakers as licensees between early April and now; 11 Chinese licensees in total, 17 contractsSince the last such announcement on March 31, four more Chinese automakers have taken an Avanci license. Geely is undoubtedly one of them.
-
Neither does the UPC need Spain and Poland β nor vice versa; but Ireland is an unfortunate outlier among non-members
Read more: Neither does the UPC need Spain and Poland β nor vice versa; but Ireland is an unfortunate outlier among non-membersThe reluctance of Poland and Spain to join the UPC is overemphasized in the UPC docket distribution debate. Realistically, only some individuals β but not the countries in question β have something to gain from UPC membership.


